Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
BeOne Medicines Ltd. American Depositary Shares (ONC) is trading at $295.27 as of May 1, 2026, posting a single-session gain of 1.54% amid muted overall market action for biopharmaceutical names. This analysis reviews recent market context for the ADS, key technical levels that have shaped recent price action, and potential near-term scenarios for traders and investors to monitor. No recent earnings data is available for ONC at this time, so price movement in recent weeks has been driven largely
What value at risk BeOne (ONC)? (Smart Money Flows) 2026-05-01 - Risk Reward Ratio
ONC - Stock Analysis
3254 Comments
786 Likes
1
Chalita
Engaged Reader
2 hours ago
Creativity and skill in perfect balance.
👍 160
Reply
2
Tynette
New Visitor
5 hours ago
Investor sentiment remains constructive, supported by broad participation and moderate trading volumes. The market is consolidating near recent highs, which may precede a continuation of the upward trend. Analysts emphasize careful monitoring of macroeconomic developments to assess potential risks.
👍 257
Reply
3
Jolly
Registered User
1 day ago
Thorough yet concise — great for busy readers.
👍 56
Reply
4
Colesha
Daily Reader
1 day ago
Investors are weighing earnings reports against broader economic data.
👍 76
Reply
5
Zyell
Trusted Reader
2 days ago
Wish I had known sooner.
👍 216
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.